0001073397-21-000004.txt : 20210430 0001073397-21-000004.hdr.sgml : 20210430 20210430165754 ACCESSION NUMBER: 0001073397-21-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210422 FILED AS OF DATE: 20210430 DATE AS OF CHANGE: 20210430 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LOPEZ GEORGE A CENTRAL INDEX KEY: 0001073397 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34634 FILM NUMBER: 21879236 MAIL ADDRESS: STREET 1: C/O ICU MEDICAL STREET 2: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92673 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ICU MEDICAL INC/DE CENTRAL INDEX KEY: 0000883984 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330022692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 BUSINESS PHONE: 949-366-2183 MAIL ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2021-04-22 0 0000883984 ICU MEDICAL INC/DE ICUI 0001073397 LOPEZ GEORGE A 951 CALLE AMANECER SAN CLEMENTE CA 92673 1 0 1 0 Common Stock 2021-04-22 4 S 0 5089 213.581 D 906754 I by Partnership Common Stock 2021-04-22 4 S 0 4926 214.636 D 901828 I by Partnership Common Stock 2021-04-22 4 S 0 1970 215.2896 D 899858 I by Partnership Common Stock 2021-04-23 4 S 0 2671 211.8199 D 897187 I by Partnership Common Stock 2021-04-23 4 S 0 6804 213.0438 D 890383 I by Partnership Common Stock 2021-04-23 4 S 0 3529 213.7942 D 886854 I by Partnership Common Stock 2021-04-23 4 S 0 11 214.64 D 886843 I by Partnership Common Stock 240314 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.09 to $214.08, inclusive. The reporting person undertakes to provide ICU Medical,Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.14 to $215.13, inclusive. The reporting person undertakes to provide ICU Medical,Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $215.16 to $215.78, inclusive. The reporting person undertakes to provide ICU Medical,Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $211.48 to $212.45, inclusive. The reporting person undertakes to provide ICU Medical,Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $212.55 to $213.52, inclusive. The reporting person undertakes to provide ICU Medical,Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.55 to $213.97, inclusive. The reporting person undertakes to provide ICU Medical,Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in this Form 4. All shares sold were sold at the exact price disclosed. By: Paula Darbyshire, Attorney-in-fact For: George A. Lopez, M.D. 2021-04-30